B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 4 980 KRW -0.3% Market Closed
Market Cap: ₩307B

BioPlus Co Ltd
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

BioPlus Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Other Current Liabilities
₩52.4B
CAGR 3-Years
130%
CAGR 5-Years
86%
CAGR 10-Years
N/A
Suheung Co Ltd
KRX:008490
Other Current Liabilities
₩30.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
17%
SD Biosensor Inc
KRX:137310
Other Current Liabilities
₩108.4B
CAGR 3-Years
-44%
CAGR 5-Years
88%
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Other Current Liabilities
₩48.6B
CAGR 3-Years
-14%
CAGR 5-Years
0%
CAGR 10-Years
42%
T
T&L Co Ltd
KOSDAQ:340570
Other Current Liabilities
₩15.8B
CAGR 3-Years
39%
CAGR 5-Years
41%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Other Current Liabilities
₩21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
11%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
307B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
8 354.09 KRW
Undervaluation 40%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Other Current Liabilities?
Other Current Liabilities
52.4B KRW

Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Other Current Liabilities amounts to 52.4B KRW.

What is BioPlus Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
86%

Over the last year, the Other Current Liabilities growth was 486%. The average annual Other Current Liabilities growth rates for BioPlus Co Ltd have been 130% over the past three years , 86% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett